Cardiac channelopathies and the molecular autopsy

Forensic Pathology of Infancy and Childhood

Volumn , Issue , 2014, Pages 899-942

  Tester, David J ^a   Ackerman, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930328531     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-61779-403-2_34     Document Type: Chapter

References (134)

1. Abiola S. Recent developments in health law. The Genetic Information Nondiscrimination Act of 2008: "first major civil rights bill of the century" bars misuse of genetic test results. J Law Med Ethics. 2008;36(4):856-60.
2. Ackerman MJ. Cardiac channelopathies: it's in the genes. Nat Med. 2004;10:463-4.
3. Ackerman MJ. Cardiac causes of sudden unexpected death in children and their relationship to seizures and syncope: genetic testing for cardiac electropathies. Semin Pediatr Neurol. 2005a;12(1):52-8.
4. Ackerman MJ. Genotype-phenotype relationships in congenital long QT syndrome. J Electrocardiol. 2005b;38(Suppl 4):64-8.
5. Ackerman MJ. State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol. 2009;32 (Suppl 2):S86-9.
6. Ackerman MJ, Tester DJ, Porter CJ, Edwards WD. Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning. N Engl J Med. 1999;341(15):1121-5.
7. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001a;286(18):2264-9.
8. Ackerman MJ, Tester DJ, Driscoll DJ. Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol. 2001b;22(2):105-11
9. Ckerman MJ, Tester DJ, Jones G, Will MK, Burrow CR, Curran M. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78:1479-87.
10. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2004;1:600-7.
11. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8):1308-39.
12. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-offunction mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115(4):442-9.
13. Arnestad M, Vege A, Rognum TO. Evaluation of diagnostic tools applied in the examination of sudden unexpected deaths in infancy and early childhood. Forensic Sci Int. 2002;125(2-3):262-8.
14. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. [see comment]. Circulation. 2007;115(3):361-7.
15. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452(1):11-8.
16. Basso C, Carturan E, Pilichou K, Rizzo S, Corrado D, Thiene G. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol. 2010;19(6):321-5.
17. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, et al. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003;362:1457.
18. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29(13):1670-80.
19. Brenner RA, Bull MJ, Agran P, Dowd MD, Garcia V, Gardner HG, et al. Prevention of drowning in infants, children, and adolescents. Pediatrics. 2003;112(2):440-5.
20. Brugada P, Benito B, Brugada R, Brugada J. Brugada syndrome: update 2009. Hellenic J Cardiol. 2009;50(5):352-72.
21. Burashnikov E, Pfeiffer R, Barajas-Martinez H, Delpón E, Hu D, Desai M, et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm. 2010;7(12):1872-82.
22. Burke A, Creighton W, Mont E, Li L, Hogan S, Kutys R, et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation. 2005;112(6):798-802.
23. Carturan E, Tester DJ, Thiene G, Ackerman MJ. Evaluation of different DNA extraction methods in archival heart tissue for postmortem mutational analysis (abstract 1518). Mod Pathol. 2006;19 Suppl 1:325A-6.
24. Charron P. Clinical genetics in cardiology. Heart. 2006;92(8):1172-6.
25. Chen PS, Priori SG. The Brugada syndrome. J Am Coll Cardiol. 2008;51(12):1176-80.
26. Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ. Spectrum and frequency of cardiac channel defects implicated in swimming-triggered arrhythmia syndromes. Circulation. 2004;110:2119-24.
27. Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation. 2000;102(6):649-54.
28. Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol. 2004;43(9):1625-9.
29. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50(2):399-408.
30. Cote A, Russo P, Michaud J. Sudden unexpected deaths in infancy: what are the causes J Pediatr. 1999;135(4):437-43.
31. Creighton W, Virmani R, Kutys R, Burke A. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. JMol Diagn. 2006;8(1):62-7.
32. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm. 2007;4(2):161-6.
33. Crotti L. Genetic predisposition to sudden cardiac death. Curr Opin Cardiol. 2011;26:46-50.
34. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80(5):795-803.
35. Delpon E, Cordeiro JM, Nunez L, Thomsen PEB, Guerchicoff A, Pollevick GD, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol. 2008;1(3):209-18.
36. Di Paolo M, Luchini D, Bloise R, Priori SG. Postmortem molecular analysis in victims of sudden unexplained death. Am J Forensic Med Pathol. 2004;25(2):182-4.
37. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. 2004;180(3):110-2.
38. Dwyer T, Ponsonby AL, Blizzard L, Newman NM, Cochrane JA. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA. 1995;273(10):783-9.
39. Eddy CA, MacCormick JM, Chung SK, Crawford JR, Love DR, Rees MI, et al. Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm. 2008;5(9):1275-81.
40. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV, et al. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm. 2011;8(7):1024-32.
41. Gladding PA, Evans CA, Crawford J, Chung SK, Vaughan A, Webster D, et al. Posthumous diagnosis of long QT syndrome from neonatal screening cards. Heart Rhythm. 2010;7(4):481-6.
42. Goldenberg I, Moss AJ, Zareba W. Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes. Curr Cardiol Rep. 2005;7(5):349-56.
43. Guntheroth WG. Theories of cardiovascular causes in sudden infant death syndrome. J Am Coll Cardiol. 1989;14(2):443-7.
44. Guyer B, Hoyert DL, Martin JA, Ventura SJ, MacDorman MF, Strobino DM. Annual summary of vital statistics-1998. Pediatrics. 1999;104(6):1229-46.
45. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail. 2009;2(3):253-61.
46. Horner JM, Ackerman MJ. Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm. 2008;5(12):1690-4.
47. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, et al. A mutation in the beta3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet. 2009;2(3):270-8.
48. Ingles J, Semsarian C. Sudden cardiac death in the young: a clinical genetic approach. Intern Med J. 2007;37(1):32-7.
49. Ingles J, Yeates L, Semsarian C. The emerging role of the cardiac genetic counselor. Heart Rhythm. 2011;8:1958-62.
50. Jons C, Moss AJ, Lopes CM, McNitt S, Zareba W, Goldenberg I, et al. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol. 2009;20(8):859-65.
51. Kanda I, Endo M. Coronary artery spasm: a hypothesis on prevention by progesterone. Med Hypotheses. 1997;49(2):183-5.
52. Kapa S, Tester DJ, Salisbury BA, Harris-Kerr C, Pungliya MS, Alders M, et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation. 2009;120(18):1752-60.
53. Kapplinger J, Tester D, Alders M, Benito B, Berthet M, Brugada J, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7(1):33-46.
54. Kattygnarath D, Maugenre S, Neyroud N, Balse E, Ichai C, Denjoy I, et al. MOG1: a new susceptibility gene for Brugada syndrome. Circ Cardiovasc Genet. 2011;4(3):261-8.
55. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104(4):569-80.
56. Kemp A, Sibert JR. Drowning and near drowning in children in the United Kingdom: lessons for prevention. BMJ. 1992;304(6835):1143-6.
57. Kinney HC, Thach BT. The sudden infant death syndrome. N Engl J Med. 2009;361(8):795-805.
58. Koopmann TT, Alders M, Jongbloed RJ, Guerrero S, Mannens M, Wilde AAM, et al. Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies. Heart Rhythm. 2006;3(1):52-5.
59. Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics. 2004;114(1):234-8.
60. Lea DH, Williams J, Donahue MP. Ethical issues in genetic testing. J Midwifery Womens Health. 2005;50(3):234-40.
61. Lee A, Ackerman MJ. Sudden unexplained death: evaluation of those left behind. Lancet. 2003;362:1429-31.
62. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334(16):1039-44.
63. Liu N, Ruan Y, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis. 2008;51(1):23-30.
64. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na + current and causes inherited arrhythmias. Circulation. 2007;116(20):2260-8.
65. Lunetta P, Levo A, Laitinen P, Fodstad H, Kontula K, Sajantila A. Molecular screening of selected long QT syndrome (LQTS) mutations in 165 consecutive bodies found in water. Int J Legal Med. 2003;117:115-7.
66. Maron BJ, Clark CE, Goldstein RE, Epstein SE. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation. 1976;54(3):423-30.
67. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. [see comment]. JAMA. 1996;276(3):199-204.
68. Medeiros-Domingo A, Bhuiyan Z, Tester D, Hofman N, Bikker H, van Tintelen J, et al. Comprehensive open reading frame mutational analysis of the RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome. J Am College Cardiol. 2009;54(22):2065-74.
69. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol. 2009;54(22):2065-74.
70. Medeiros-Domingo A, Tan BH, Crotti L, Tester DJ, Eckhardt L, Cuoretti A, et al. Gain-offunction mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm. 2010;7(10):1466-71.
71. Michaud K, Fellmann F, Abriel H, Beckmann JS, Mangin P, Elger BS. Molecular autopsy in sudden cardiac death and its implication for families: discussion of the practical, legal and ethical aspects of the multidisciplinary collaboration. Swiss Med Wkly. 2009;139(49-50):712-8.
72. Migdalovich D, Moss AJ, Lopes CM, Costa J, Ouellet G, Barsheshet A, et al. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for lifethreatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011;8(10):1537-43.
73. Morentin B, Suarez-Mier MP, Aguilera B. Sudden unexplained death among persons 1-35 years old. Forensic Sci Int. 2003;135(3):213-7.
74. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ethera-go-go-related gene potassium channel. Circulation. 2002;105:794-9.
75. Moss AJ, Windle JR, Hall WJ, Zareba W, Robinson JL, McNitt S, et al. Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol. 2005;10(Suppl 4):59-66.
76. Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115(19):2481-9.
77. Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. [see comment]. J Cardiovasc Electrophysiol. 2008;19(12):1289-93.
78. Nagaoka I, Shimizu W, Itoh H, Yamamoto S, Sakaguchi T, Oka Y, et al. Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome. Circ J. 2008;72(5):694-9.
79. Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. [see comment]. JAMA. 2005;294(23):2975-80.
80. Nishio H, Iwata M, Suzuki K. Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death: R420W mutated case with characteristics of status thymico-lymphatics. Circ J. 2006;70(11):1402-6.
81. Oliva A, Brugada R, D'Aloja E, Boschi I, Partemi S, Brugada J, et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol. 2011;32(1):1-16.
82. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest. 2006;116(2):430-5.
83. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99(4):529-33.
84. Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet. 2000;355(9206):808-9.
85. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106(1):69-74.
86. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, et al. Clinical aspects and prognosis of Brugada syndrome in children. [see comment]. Circulation. 2007;115(15):2042-8.
87. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2(12):1277-82.
88. Ruan Y, Liu N, Priori SG. Sodium channel mutations and arrhythmias. Nat Rev Cardiol. 2009;6(5):337-48.
89. Schwartz PJ. Cardiac sympathetic innervation and the sudden infant death syndrome: a possible pathogenic link. Am J Med. 1976;60(2):167-72.
90. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998;338(24):1709-14.
91. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343(4):262-7.
92. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotypephenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95.
93. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. [see comment]. Circulation. 2009;120(18):1761-7.
94. Semsarian C, Hamilton RM. Key role of the molecular autopsy in sudden unexpected death. Heart Rhythm. 2011;9:145-50.
95. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J. 2008;72(12):1926-36.
96. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, et al. Mutation sitespecific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome. J Am Coll Cardiol. 2004;44:117-25.
97. Shimizu W, Moss A, Wilde A, Towbin J, Ackerman M, Tester D, et al. Genotype-phenotype aspects of type-2 long-QT syndrome. J Am Coll Cardiol. 2009;54(22):2052-62.
98. Skinner JR, Duflou JA, Semsarian C. Reducing sudden death in young people in Australia and New Zealand: the TRAGADY initiative. Med J Aust. 2008;189(10):539-40.
99. Skinner JR, Crawford J, Smith W, Aitken A, Heaven D, Evans C-A, et al. Prospective, populationbased long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm. 2011;8(3):412-9.
100. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102(10):1178-85.
101. Splawski I, Timothy KW, TateyamaM, Clancy CE, Malhotra A, Beggs AH, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297(5585):1333-6.
102. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112(2):207-13.
103. Tan B-H, Pundi KN, Van Norstrand DW, Valdivia CR, Tester DJ, Medeiros-Domingo A, et al. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm. 2010;7(6):771-8.
104. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the cardiac channelopathies Cardiovasc Res. 2005;67:388-96.
105. Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol. 2006;21(3):166-72.
106. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. [see comment]. J Am Coll Cardiol. 2007;49(2):240-6.
107. Tester DJ, Ackerman MJ. Genetic testing. In: Gussak I, Antzelevitch C, editors. Electrical diseases of the heart: genetics, mechanisms, treatment, prevention. London: Springer; 2008. p. 444-58.
108. Tester DJ, Ackerman MJ. Genetics of cardiac arrhythmias. In: Braunwald's heart disease: a textbook of cardiovascular medicine. Philadelphia: Elsevier/Saunders; 2012. p. 81-90.
109. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc. 2004;79:1380-4.
110. Tester DJ, Kopplin LJ, Creighton W, Burke AP, Ackerman MJ. Pathogenesis of unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc. 2005a;80:596-600.
111. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005b;2:507-17.
112. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm. 2007;4(6):733-9.
113. Tester DJ, Benton AJ, Train L, Deal B, Baudhuin LM, Ackerman MJ. Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am J Cardiol. 2010;106(8):1124-8.
114. Tester D, Medeiros-Domingo A, Will M, Ackerman M. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series. Mayo Clin Proc. 2011a;86(10):941-7.
115. Tester DJ, Tan B-H, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ. Loss-offunction mutations in the KCNJ8-encoded Kir6.1 KATP channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011b;4:510-5.
116. Tester D, Medeiros-Domingo A, Will M, Ackerman M. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc. 2012;87(6):524-39.
117. Thomas SM. Society and ethics-The genetics of disease. Curr Opin Genet Dev. 2004;14(3):287-91.
118. (TRAGADY [Trans-Tasman Response Against Sudden Death in the Young]), T.-T. R. A. S. D. i. t. Y. Post-mortem in sudden unexpected death in the young: guidelines on autopsy practice. Royal College of Pathologists of Australasia, Sydney; 2008 http:/www.rcpa.edu.au/applications/DocumentLibraryManager2/upload/SUDYbestpracticedocumentendorsedMay2708%20(2).pdf. Accessed Oct 2011.
119. Valdes-Dapena MA. Editorial: sudden, unexpected and unexplained death in infancy-A status report-1973. N Engl J Med. 1973;289(22):1195-7.
120. van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal AC, et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm. 2010;7(10):1383-9.
121. Van Norstrand DW, Valdivia CR, Tester DJ, Ueda K, London B, Makielski JC, et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation. 2007;116(20):2253-9.
122. Van Norstrand DW, Medeiros-Domingo A, Tester DJ, Cheng J, Valdivia CR, Makielski JC, et al. Missense mutations in SNTA1-encoded syntrophin alpha and sudden infant death syndrome. Circulation. 2008a;118(18 Suppl 2):S812-3.
123. Van Norstrand DW, Tester DJ, Ackerman MJ. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm. 2008b;5(5):712-5.
124. Van Riper M. Genetic testing and the family. J Midwifery Womens Health. 2005;50(3):227-33.
125. Villain E, Denjoy I, Lupoglazoff JM, Guicheney P, Hainque B, Lucet V, et al. Low incidence of cardiac events with B-blocking therapy in children with long QT syndrome. Eur Heart J. 2004;25:1405-11.
126. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, et al. High efficacy of betablockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures". [see comment]. Circulation. 2009;119(2):215-21.
127. Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovasc Pathol. 2001;10(6):275-82.
128. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80(5):805-11.
129. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12(1):17-23.
130. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott J-J, et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118(6):2260-8.
131. Wever EF, Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004;43(7):1137-44.
132. Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol. 1991;11(5):677-84.
133. Yang Y, Yang Y, Liang B, Liu J, Li J, Grunnet M, et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet. 2010;86(6):872-80.
134. Yun AJ, Lee PY. Sudden death among infants and adults: companion disorders of maladaptive sympathetic bias. Med Hypotheses. 2004;62(6):857-60.